Abstract
Herein we report on an improved method for the microscale extraction of huperzine A (HupA), an acetylcholinesterase-inhibiting alkaloid, from as little as 3 mg of tissue homogenate from the clubmoss Huperzia squarrosa (G. Forst.) Trevis with 99.95 % recovery. We also validated a novel UHPLC-QTOF-MS method for the high-throughput analysis of H. squarrosa extracts in only 6 min, which, in combination with the very low limit of detection (20 pg on column) and the wide linear range for quantification (20 to 10,000 pg on column), allow for a highly efficient screening of extracts containing varying amounts of HupA. Utilization of this methodology has the potential to conserve valuable plant resources.
Keywords: alkaloid, Huperzia, huperzine A, mass spectrometry, microscale extraction
Introduction
The traditional Chinese herbal medicine Qian Ceng Ta, a hot infusion prepared from whole plant material of the club moss Huperzia serrata (Thunb. ex Murray) Trevis, has been used for more than 1,000 years (earliest written record in 739 A.D.) for the treatment of swellings, contusions, neuromuscular disease and schizophrenia (reviewed in Ma et al., 2007). In vitro and in vivo studies demonstrated that alkaloid-containing extracts from members of the Huperziaceae and Lycopodiaceae had inhibitory effects on acetylcholinesterase (AChE) (Cheng et al., 1986; Tang et al., 1989; Tang, 1996; Raves et al., 1997). This enzyme is currently one of the most promising drug targets for the symptomatic treatment of cardiovascular and neuromuscular conditions, including Alzheimer’s disease (AD). The active principles of Huperzia serrata extracts, the lycodine alkaloids huperzine A (HupA) and huperzine B, were isolated and identified in the 1980s (Liu and Zhu, 1986). HupA has undergone successful phase IV clinical trials in China, which indicated that it improves cognitive function in patients suffering from AD (Xu et al., 1995; Xu et al., 1999; Zhang et al., 2002).
HupA occurs at low levels in members of the Huperziaceae (Ma et al., 2005). Within this family the genus Huperzia consists of 10–15 species with temperate to arctic distribution, while the genus Phlegmariurus comprises primarily epiphytic species native to tropical and subtropical habitats. Several chemical syntheses of HupA have been published to date (reviewed in Ma et al., 2007), but poor yields have excluded commercial applications and the primary source of HupA is still H. serrata. However, there are several challenges affecting this method of production. Species belonging to the Huperzia genus are known for their very slow growth rate of only a few centimeters per year and are difficult to propagate in vitro (Ma and Gang, 2008). Because of over-harvesting for medicinal preparations, H. serrata may soon become an endangered species (Ma et al., 2006).
Species belonging to the Huperziaceae and Lycopodiaceae are known to accumulate large amounts of mannose-containing polysaccharides (Popper and Fry, 2004), which can interfere with the isolation of alkaloids. The combination of relatively low HupA quantities in Huperzia species and difficulties with its extractability have necessitated continuous improvements in analytical protocols (Ma et al., 2005; Borloz et al., 2006; Wu and Gu 2006; Pan et al., 2006; Goodger et al., 2008; Wang et al., 2009, Zhang et al. 2009; Yu et al., 2010). To further advance these efforts we have developed an optimized microscale extraction protocol for tissue extracts of Huperzia squarrosa (G. Forst.) Trevis, a club moss growing in temperate and tropical habitats of Southeast Asia and Australasia. Subsequent high-throughput analysis of HupA was achieved using an Ultrahigh Performance Liquid Chromatography system coupled to a Quadrupole Time-Of-Flight Mass Spectrometer (UHPLC-QTOF-MS).
Experimental
Reagents
Liquid chromatography solvents were obtained from EMD Biosciences (Gibbstown, NJ) and Burdick & Jackson (Morristown, NJ). Authentic HupA standard was obtained from Sigma-Aldrich (St. Louis, MO). The internal standard atropine was purchased from MP Biomedicals (Solon, OH).
Plant growth
Cuttings of H. squarrosa were obtained from the University of Colorado (greenhouse of the Department of Ecology and Evolutionary Biology). The cuttings were rooted in Perlite soil (Portland, OR) and grown under natural daylight, at an average humidity of 60 % and an average temperature of 23°C. A voucher specimen of H. squarrosa was deposited at the Field Museum at the University of Illinois (no. 2294678).
HupA extraction
Metabolite extractions were generally performed from tissue of actively growing sporophytes. Tissue was shock-frozen in liquid nitrogen immediately after harvest, ground to a powder using mortar and pestle, and dried to a constant weight in a freeze-drier. Roughly 3 mg of freeze-dried tissue was extracted with 2 mL of an aqueous acetic acid solution (2 %; v/v containing 2.7 μg/mL of the tropane alkaloid atropine, which does not occur in H. squarrosa and is used as a standard to calculate losses during the extraction procedure), by vigorous mixing for 10 min (Vortex mixer at highest speed) and subsequent sonication in an ultrasonic bath for 30 min at 23°C. The liquid phase was separated from tissue debris by spinning at 2,500 x g for 2 min. This extraction step was repeated with another 2 mL of 2 % acetic acid. The pooled supernatants were extracted once with 3 mL CHCl3. The (lower) chloroform layer was discarded and the pH of the aqueous layer adjusted to pH 11 using 9 M aqueous ammonia. The basic aqueous solution was extracted twice with 3 mL CHCl3, and the chloroform fractions were pooled and dried under reduced pressure. The residue was dissolved in 300 μL methanol and passed through a 0.45 μm PTFE syringe filter (Millipore, Billerica, MA) directly into a 2.5-mL HPLC glass vial (Agilent Technologies, Santa Clara, CA). Extracts were placed on a chilled (4°C) autosampler and analyzed within 12 h. Variability of column loading was assessed by injecting one sample 10 times and was found to be negligible (< 2 % variation).
HupA analysis by UHPLC-QTOF-MS
HupA analyses were performed by high resolution mass spectrometry (MS) and tandem mass spectrometry (MS/MS) experiments using an Agilent 1290 UHPLC system coupled to an Agilent 6520 QTOF mass spectrometer equipped with a Atmospheric Pressure Chemical Ionization (APCI) source. Instrument control and data acquisition utilized MassHunter Acquisition Software (Revision B.02.01). MS and MS/MS data were processed and analyzed with Agilent’s MassHunter Qualitative Analysis Software (Revision B.03.01). Chromatographic separations were achieved on a Zorbax Eclipse Plus C18 (2.1 × 50 mm, 1.8 μm particle size) analytical column. The temperature of the column compartment was kept at 60°C. The injection volume was typically set to 2 μL. The flow rate was 1.3 mL/min using 0.2 % aqueous acetic acid as solvent A and 0.2% acetic acid in methanol as solvent B. A linear gradient was applied from 98% A and 2% B to 2% A and 98% B at 3 min (plus an additional hold at 98% B for another 1 min). The column was re-equilibrated for 2 min between runs. The QTOF mass spectrometer was set to 2 GHz high gain in positive ion mode for MS experiments and 4 GHz high resolution mode for MS/MS experiments, with the following additional settings: the drying gas flow was 5 L min−1, the nebulizer pressure was 60 psi, the drying gas temperature was 325°C, and the APCI source vaporizer temperature was 450°C. Scan rates were set to 1.4 scans s−1 for MS and to 4 scans s−1 for MS/MS. For fragmentation of HupA the [M+H]+ peak at m/z 243.149 was targeted. MS and MS/MS spectrometric peaks were annotated using accurate mass data for molecular formula generation in Agilent’s MassHunter qualitative analysis software. Serial dilutions of the HupA standard were prepared from a 1 mg/mL stock solution in methanol, and the linearity of the QTOF mass spectrometer was assessed in the range of 0.01–100 μg/mL HupA, which corresponds to on-column injections of Hup A of 20–2,000 pg. A calibration curve with excellent linearity for the range of 0.01–50 μg/mL HupA (R2 = 0.998) was used for quantification purposes.
Recovery
The recovery of HupA from 2% acetic acid extracts was evaluated using roughly 3 mg (dry weight) of pooled (scales and stems), finely ground, tissue samples of H. squarrosa. Three sets of five replicate tissue samples were prepared by (set 1) spiking with 2.37 ug of Huperzine A before extraction, (set 2) spiking 2.37 ug of Huperzine A after extraction, and (set 3) processing the tissue without spiking. Extracts (2 μL) were analyzed using a UHPLC-QTOF mass spectrometer. The recovery (R) was determined using the following equation:
Matrix effects
To determine the effects of the biological matrix on the quantification of HupA, we extracted 3 mg (dry weight) of pooled (scales and stems), finely ground, tissue samples of H. lucidula, a close relative of H. squarrosa that does not accumulate detectable levels of HupA. These extracts were then spiked with HupA (final concentration of 0.01–50 μg/mL) and analyzed by UHPLC-QTOF-MS. These results were compared to those obtained with neat standard solutions of the same concentration and the difference between these values was used to adjust peak areas for matrix effects.
Results and discussion
Development of a UHPLC-QTOF-MS method for huperzine A analysis
Three HPLC-MS-based methods for HupA analysis have been published previously (Wu and Gu, 2006; Borloz et al., 2006; Ma and Gang, 2008). Our initial optimization focused on shortening the chromatographic run time, while preserving the separation of HupA from potentially interfering metabolites contained in H. squarrosa extracts. A UHPLC gradient from 98% solvent A (0.2 % acetic acid) to 98 % solvent B (0.2 % acetic acid in methanol) using a porous, low particle-size, reversed-phase column operated at 1.3 mL/min enabled the analysis of HupA in H. squarrosa within only 6 min (incl. re-equilibration) (Fig. 1). Under these conditions the HupA authentic standard eluted at 0.6 min (retention factor k′ = 4.1). An isocratic elution of HupA was unsuccessful, as H. squarrosa extracts contained a metabolite with a closely related m/z value that could only be separated by gradient HPLC. HupA did not ionize at all in APCI(−) mode and only a low signal was detected in ESI(−) mode. In ESI(+) mode the [M+H]+ and the corresponding sodium adduct and dimers were detected with moderate sensitivity. In APCI(+) mode the [M+H]+ ion was detected with exquisite sensitivity (17-fold higher abundance than in ESI(+) mode), while the sodium adduct and the protonated dimer were not detected (Fig. 1). All further analyses were thus performed in APCI(+) mode. MS/MS spectra of the HupA authentic standard and HupA present in H. squarrosa extracts had characteristic fragments at m/z 226.12 (loss of NH3) and m/z 210.09 (Fig. 1).
Fig. 1.
Identification of HupA in H. squarrosa extracts. (A) Total Ion Current (TIC) and (B) Extracted Ion Chromatograms (EIC) obtained by UHPLC-QTOF-MS in APCI (+) mode for the HupA standard (red trace) and the 1 % acetic acid extract (black trace). HupA elutes at 0.62 min. (C) MS and (D) MS/MS spectra of the H. squarrosa extract at 0.62 min. (E) MS and (F) MS/MS spectra of the authentic HupA standard at 0.62 min. The following fragments were identified in the MS/MS spectra of the extract: (1) 243.1477 = [M+H]+, (2) 226.1225 (loss of NH3), and (3) 210.0890 (unannotated).
The linear range of detection was from 0.01 to 50 μg/mL (R2 = 0.998; Table 1), corresponding to 20–100,000 pg injected on column. The limit of detection (signal-to-noise (S/N) ratio of 3:1) and the limit of quantification (S/N ratio of 10:1) were determined as 5.1 and 17.2 ng/mL, respectively. These values correspond to 10.2 and 17.2 pg injected on column, respectively (Table 1), which is a significant improvement over the most sensitive previously published protocols (Ma et al., 2005; Zhang et al., 2009). The intraday variation of the method, determined as the relative standard deviation (RSD) of replicate measurements of HupA was at 7.1% at a low concentration (0.1 μg/mL) and decreased to 1.3% at higher concentrations (50 μg/mL). The RSD for interday precision ranged between 6.5 and 7.6% for lower concentrations (0.1–10 μg/mL) and was lower (3.7%) at the highest concentration (50 μg/mL).
Table 1.
Validation of a UHPLC-QTOF-MS method for the analysis of HupA.
Retention Factor | Linearity | R2 | LOD (S/N = 3:1) | LOQ (S/N = 10:1) | Intraday Precision* (N ≥ 6) (RSD [%]) | Interday Precision* (N ≥ 5) (RSD [%]) | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||
Concentration of Authentic Standard Solution | ||||||||||||
0.1 μg/mL | 1 μg/mL | 10 μg/mL | 50 μg/mL | 0.1 μg/mL | 1 μg/mL | 10 μg/mL | 50 μg/mL | |||||
| ||||||||||||
Values for neat standard solutions | ||||||||||||
4.1 | 0.01 – 50 μg/mL | 0.998 | 5.1 ng/mL | 17.2 ng/mL | ||||||||
20 – 100,000 pg (OC) | 10.2 pg (OC) | 34.4 pg (OC) | 7.1 | 1.7 | 3.4 | 1.3 | 6.5 | 7.0 | 7.6 | 3.7 | ||
Values for neat standard solutions in the presence of aHuperzia matrix | ||||||||||||
4.1 | 0.015 – 50 μg/mL | 0.997 | 10.1 ng/mL | 33.7 ng/mL | ||||||||
30 – 100,000 pg (OC) | 20.2 pg (OC) | 67.4 pg (OC) | 7.1 | 1.7 | 3.4 | 1.3 | 6.5 | 7.0 | 7.6 | 3.7 |
LOD, Limit Of Detection; LOQ, Limit Of Quantification; OC, Amount Injected On Column; S/N, Signal-to-Noise Ratio.
Impact of matrix effects on huperzine A quantification by UHPLC-QTOF-MS
When separations using HPLC or UHPLC are combined with MS or MS/MS detectors, matrix effects can lead to ion suppression or enhancement, thus leading to potentially incorrect quantifications of target analytes. To evaluate the relevance of matrix effects for the detection of HupA in H. squarrosa, we used extracts from a closely related species, H. lucidula, which did not contain any detectable amounts of HupA. These extracts were spiked with known concentrations of HupA and the obtained peak areas in UHPLC-QTOF-MS analyses compared to those acquired analogously with neat HupA standards of equivalent concentrations. The peak area difference was then used to determine matrix effects according to established methods (Matuszewski et al., 2003). The slopes of both curves (spiked extracts and neat standard) were nearly identical (Fig. 2). The only significant difference was that the HupA peak intensity dropped near the limit of detection in the presence of the Huperzia matrix. In the presence of a Huperzia matrix, the limit of detection was determined as 10.1 ng/mL or 20.2 pg (42.1 fmol on-column) and the limit of quantification was 33.7 ng/mL or 67.4 pg (141.9 fmol) on-column.
Fig. 2.
Evaluation of matrix effects on HupA detection by UHPLC-QTOF-MS. The blue line indicates the calibration curve with neat HupA standard (N = 6), while the red line indicates measured peak areas for known quantities of HupA spiked into an extract obtained from H. lucidula, a close relative of H. squarrosa that does not contain detectable levels of HupA (N = 6). Standard deviations are indicated, but are mostly smaller than the symbols used to plot the mean of the measurements.
Recovery of huperzine A from H. squarrosa extracts
HupA was extracted using a standard protocol with an initial acid treatment of finely ground tissue samples, an extraction with CHCl3 to remove potentially interfering metabolite, an alkalinization of the extract to protonate HupA, and a second extraction with CHCl3 to transfer the now protonated HupA into the organic phase (Ma et al., 2005). The only differences to this traditional protocol were a few adjustments for a smaller scale extraction and the use of 2 % acetic acid instead of 2 % tartaric acid, as this resulted in extracts containing fewer metabolites potentially interfering with a rapid and sensitive HupA analysis (data not shown). For the calculation of extraction recoveries we used a standard method validation protocol that is based on a spiking approach (Hartmann et al., 1998). Samples were analyzed in three ways using UHPLC-QTOF-MS: (i) by acetic acid extraction without modifications (‘Sample’ column in Table 2); (ii) by adding a known quantity of authentic HupA standard to the extraction solvent prior to tissue processing (‘Sample Spiked Before Extraction’ column in Table 2); and (iii) by adding a known quantity of authentic HupA standard to the extract after completing the tissue extraction (‘Sample Spiked After Extraction’ column in Table 2). These experiments were performed with 3 mg (dry weight) of H. squarrosa tissue, which is approximately 1/7 the tissue amount required for the least tissue-consuming protocol published to date (Ma and Gang, 2008). The recovery for HupA was 99.95%, indicating only marginal losses during the extraction (Table 2).
Table 2.
Recovery of HupA from H. squarrosa extracts. Presented values reflect normalized peak areas.
Replicate | Sample (3 mg) | Sample Spiked Before Extraction | Sample Spiked After Extraction |
---|---|---|---|
1 | 534319 | 1108856 | 1105289 |
2 | 658796 | 1081894 | 1014307 |
3 | 668484 | 1031501 | 1025945 |
4 | 647848 | 1081574 | 1137156 |
5 | 621004 | 1073785 | 1096033 |
Mean | 626090 | 1075522 | 1075746 |
SD | 54287 | 27970 | 53175 |
RSD [%] | 8.7 | 2.6 | 4.9 |
R [%] | 99.95 |
R, Recovery; RSD, Relative Standard Deviation; SD, Standard Deviation.
Quantification of huperzine A in H. squarrosa
Using our newly developed and validated UHPLC-QTOF-MS protocol the HupA concentration in greenhouse-grown H. squarrosa sporophytes was determined to be 415.3 μg/g dry weight (Table 3), which is very similar to previously published values for field specimen harvested in China (378.8 μg/g; Ma et al., 2005). We also separated scales and stems prior to the extraction and obtained HupA concentrations of 928.0 and 317.7 μg/g dry weight, respectively. These results indicate that scales are a roughly 3-fold richer source of HupA compared to stems, which had not been evaluated previously. These results have implications for studies on the biosynthesis of HupA, as the tissue-level localization of the biosynthetic pathway is currently unknown.
Table 3.
Distribution of HupA in different tissues of H. squarrosa.
Hup A Concentration (Dry Weight) [μg/g] | |||
---|---|---|---|
| |||
Sporophyte (N = 8) | Scales (N = 6) | Stems (N = 6) | |
Mean | 415.3 | 928.0 | 317.7 |
SD | 29.6 | 40.8 | 28.0 |
RSD [%] | 7.1 | 4.4 | 8.8 |
RSD, Relative Standard Deviation.
SD, Standard Deviation.
Conclusions
Our new UHPLC-QTOF-MS method for the analysis of HupA from Huperzia offers advanced with regard to sensitivity (and a concomitant decrease in the amount of required plant material) and chromatographic run time. This new method is highly valuable for rapidly determining HupA concentrations in Huperzia, even when plant material is limited.
Acknowledgments
This research was funded in part by the National Institutes of Health (grant # 5RC2GM092561-02). The authors would like to thank Thomas Lemieux (University of Colorado) for providing cuttings of H. squarrosa. We would also like to thank the greenhouse staff at the Institute of Biological Chemistry (Amy Hetrick, Julia Gothard-Szamosfalvi, Sue Vogtman and Craig Whitney) for maintaining plants.
References
- Borloz A, Marston A, Hostettmann K. The determination of Huperzine A in European Lycopodiaceae species by HPLC-UV-MS. Phytochemical Analysis. 2006;17:332–336. doi: 10.1002/pca.922. [DOI] [PubMed] [Google Scholar]
- Cheng YS, Lu CZ, Ying ZL, Ni WY, Zhang CL, Sang GW. 128 Cases of Myasthenia gravis treated with huperzine A. Chinese Journal of New Drugs and Clinical Remedies. 1986;5:197–199. [Google Scholar]
- Goodger JQD, Whincup AL, Field AR, Holtum JAM, Woodrow IE. Variation in huperzine A and B in Australasian Huperzia species. Biochemical Systematics and Ecology. 2008;36:612–618. [Google Scholar]
- Hartmann C, Smweyers-Verbeke J, Massart DL, McDowall RD. Validation of bioanalytical chromatographic methods. Journal of Pharmaceutical and Biomedical Analysis. 1998;17:193–218. doi: 10.1016/s0731-7085(97)00198-2. [DOI] [PubMed] [Google Scholar]
- Liu J-S, Zhu Y-L. The structures of huperzine A and B, two new alkaloids exhibiting marked anticholinesterase activity. Canadian Journal of Chemistry. 1986;64:837–839. [Google Scholar]
- Ma X, Gang DR. In vitro production of huperzine A, a promising drug candidate for Alzheimer’s disease. Phytochemistry. 2008;69:2022–2028. doi: 10.1016/j.phytochem.2008.04.017. [DOI] [PubMed] [Google Scholar]
- Ma X, Tan C, Zhu D, Gang DR. A survey of potential huperzine A natural resources in China: the Huperziaceae. Journal of Ethnopharmacology. 2006;104:54–67. doi: 10.1016/j.jep.2005.08.042. [DOI] [PubMed] [Google Scholar]
- Ma X, Tan C, Zhu D, Gang DR. Is there a better source of Huperzine A than Huperzia serrata? Huperzine A content of Huperziaceae Species in China. Journal of Agricultural and Food Chemistry. 2005;53:1393–1398. doi: 10.1021/jf048193n. [DOI] [PubMed] [Google Scholar]
- Ma X, Tan C, Zhu D, Gang DR, Xiao P. Huperzine A from Huperzia species – An ethnopharmacological review. Journal of Ethnopharmacology. 2007;113:15–34. doi: 10.1016/j.jep.2007.05.030. [DOI] [PubMed] [Google Scholar]
- Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Analytical Chemistry. 2003;75:3019–3030. doi: 10.1021/ac020361s. [DOI] [PubMed] [Google Scholar]
- Pan J, Jin R, Hu X. Application of L-amino acid in determination of huperzine A by high performance liquid chromatography. Journal of Chromatography B. 2006;836:108–110. doi: 10.1016/j.jchromb.2006.03.018. [DOI] [PubMed] [Google Scholar]
- Popper ZA, Fry SC. Primary cell wall composition of pteridophytes and spermatophytes. New Phytologist. 2004;164:165–174. doi: 10.1111/j.1469-8137.2004.01146.x. [DOI] [PubMed] [Google Scholar]
- Raves ML, Harel M, Pang YP, Silman I, Kozikowski AP, Sussman JL. Structure of acetylcholinesterase complexed with the nootropic alkaloid, (−)-huperzine A. Nature Structural Biology. 1997;4:57–63. doi: 10.1038/nsb0197-57. [DOI] [PubMed] [Google Scholar]
- Tang XC, De Sarno P, Sugaya K, Giacobini E. Effect of huperzine A, a new cholinesterase inhibitor, on the central cholinergic system of the rat. Journal of Neuroscience Research. 1989;24:276–285. doi: 10.1002/jnr.490240220. [DOI] [PubMed] [Google Scholar]
- Tang XC. Huperzine A shuangyiping: a promising drug for Alzheimer’s disease. Zhongguo Yao Li Xue Bao. 1996;17:481–484. [PubMed] [Google Scholar]
- Wang G, Cao Q, Zhu X, Yang X, Yang M, Ding Z. Molecular imprinted solid-phase extraction of Huperzine A from Huperzia serrata. Journal of Applied Polymer Science. 2009;113:3049–3058. [Google Scholar]
- Wu Q, Gu Y. Quantification of huperzine A in Huperzia serrata by HPLC-UV and identification of the major constituents in its alkaloid extracts by HPLC-DAD-MS-MS. Journal of Pharmaceutical and Biomedical Analysis. 2006;40:993–998. doi: 10.1016/j.jpba.2005.07.047. [DOI] [PubMed] [Google Scholar]
- Xu SS, Cai ZY, Qu ZW, Yang RM, Cai YL, Wang GQ, Su XQ, Zhong XS, Cheng RY, Xu WA, Li JX, Feng B. Huperzine A in capsules and tablets for treating patients with Alzheimer’s disease. Zhongguo Yao Li Xue Bao. 1999;20:486–490. [PubMed] [Google Scholar]
- Xu SS, Gao ZX, Weng Z, Du ZM, Xu WA, Yang JS, Zhang ML, Tong ZH, Fang YS, Chai XS, et al. Efficacy of tablet huperzine A on memory, cognition, behavior in Alzheimer’s disease. Zhongguo Yao Li Xue Bao. 1995;16:391–395. [PubMed] [Google Scholar]
- Yu L, Shi Y, Huang J, Gong Y, Liu Z, Hu W. Modification and validation of a high-performance liquid chromatography method for quantification of huperzine A in Huperzia crispa. Journal of AOAC International. 2010;93:1428–1435. [PubMed] [Google Scholar]
- Zhang Y, Xie J, Chen W-Q, Zhou T-Y, Lu W. Development of a sensitive high-performance liquid chromatographic method with simple extraction for simultaneous determination of huperzine A and huperzine B in the species containing Lycopodium alkaloids. Journal of AOAC International. 2009;92:1060–1063. [PubMed] [Google Scholar]
- Zhang Z, Wang X, Chen Q, Shu L, Wang J, Shan G. Clinical efficacy and safety of huperzine alpha in treatment of mild to moderate Alzheimer disease. A placebo-controlled, double-blind, randomized trial. Zhonghua Yi Xue Za Zhi. 2002;82:941–944. [PubMed] [Google Scholar]